RAQUALIA PHARMA INC.

Business Segments RaQualia Pharma Inc.

Stocks

4579

JP3967150008

Pharmaceuticals

Delayed Japan Exchange Other stock markets 06:31:15 15/06/2026 am IST			5-day change	1st Jan Change
464.00 ^JPY	+1.09%		-3.33%	-54.06%

15/05	RaQualia Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
13/02	RaQualia Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (JPY)

Fiscal Period: December	2014	2017	2018	2019	2020	2021	2022	2023	2024	2025
Pharmaceutical Products
Pharmaceutical Research and Development and Related Businesses						277.6Cr	291.8Cr	190.1Cr	310.7Cr	397.9Cr
Total Assets						523.4Cr	625.7Cr	687.1Cr	965.5Cr	1.05TCr
Interest Expense						-10L	-60L	-70L	-4.2Cr	-5.9Cr
Income Tax Expense						12Cr	13Cr	2.9Cr	14Cr	16Cr
CAPEX						-10Cr	-3.1Cr	-20Cr	-9.6Cr	-6.7Cr
EBT						88Cr	85Cr	-29Cr	-36Cr	44Cr
Gross Profit						277.6Cr	291.8Cr	190.1Cr	310.7Cr	326.8Cr
D&A						14Cr	15Cr	18Cr	60Cr	77Cr
Operating Income						71Cr	87Cr	-34Cr	-21Cr	48Cr
Net Income						76Cr	72Cr	-32Cr	-50Cr	27Cr

Geographical Revenue Distribution History

Geographical breakdown of sales (JPY)

Fiscal Period: December	2014	2017	2018	2019	2020	2021	2022	2023	2024	2025
Asia						58Cr	103.4Cr	80Cr	125.56Cr	205.15Cr
Japan						118.73Cr	74Cr	61.11L	71Cr	106.75Cr
Total Assets						30Cr	39Cr	57Cr	53Cr	44Cr
United States of America						100.41Cr	114.24Cr	109.08Cr	112.88Cr	86Cr
Others						-	-	35.07L	1.23Cr	-

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!